Canine Arthritis Treatment Market Report 2026

Canine Arthritis Treatment Market Overview

• Canine Arthritis Treatment market size has reached to $2.47 billion in 2025 • Expected to grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 4.7% • Growth Driver: Rising Pet Ownership Rates Drive Growth In Canine Arthritis Treatment Market • Market Trend: Innovative Solutions Enhanced Canine Arthritis Treatments Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Canine Arthritis Treatment Market?

Canine arthritis treatment refers to the medical and therapeutic approaches for canine arthritis disease, a chronic condition characterized by inflammation and progressive deterioration of the cartilage within a dog's joints. It is used to reduce pain and inflammation, maintain joint function, and slow the progression of the disease in dogs. The main treatments are drugs, supplements, surgical procedures, and others. A canine arthritis drug refers to medication specifically designed to alleviate symptoms and manage arthritis in dogs. Administered orally, parenterally, and via other routes, this treatment targets diseases such as osteoarthritis, rheumatoid arthritis, osteochondrosis, and traumatic arthritis. Distributed through veterinary clinics and hospitals, retail pharmacies, and online platforms, it serves diverse end-users including veterinary hospitals, drug stores, and e-commerce.

What Is The Canine Arthritis Treatment Market Growth Forecast?

The canine arthritis treatment market size is expected to see steady growth in the next few years. It will grow to $3.13 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to development of targeted biologic therapies, increasing adoption of precision medicine in veterinary care, innovation in surgical techniques for joint repair, growth of online and retail veterinary pharmacies, rising investment in stem cell and prp research. Major trends in the forecast period include rising adoption of non-steroidal anti-inflammatory drugs (nsaids), increased use of joint supplements like glucosamine and chondroitin, growth in stem cell therapy and platelet-rich plasma (prp) treatments, expansion of minimally invasive surgical procedures for dogs, integration of physical therapy and cold laser therapy in arthritis management.

Global Canine Arthritis Treatment Market Segmentation

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types 2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations 3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis 4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers 2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements 3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy 4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

What Is The Driver Of The Canine Arthritis Treatment Market?

The rising pet ownership rate is expected to propel the growth of the canine arthritis treatment market going forward. Pet ownership refers to the responsibility and care taken by individuals or households in providing for the needs, well-being, and companionship of domesticated animals kept primarily for pleasure rather than utility. The rising pet ownership rates are due to factors such as lifestyle changes, the humanization of pets, and higher disposable incomes. Pet owners use canine arthritis treatments to manage and alleviate the symptoms of arthritis in their dogs, aiming to improve their pets' quality of life and maintain mobility. For instance, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, making pets an integral part of more than half of Canadian households. Therefore, the rising pet ownership rate is driving the growth of the canine arthritis treatment industry.

Key Players In The Global Canine Arthritis Treatment Market

Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill's Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Global Canine Arthritis Treatment Market Trends and Insights

Major companies operating in the canine arthritis treatment market are developing innovative treatments, such as bedinvetmab injections, to address canine joint health and mobility. Bedinvetmab is a monoclonal antibody injection that works by targeting and neutralizing nerve growth factor (NGF), a protein involved in pain used in veterinary medicine. For instance, in May 2023, Zoetis Inc., a US-based animal health company, received approval from the Food and Drug Administration (FDA) for Librela, a bedinvetmab injection. It is the first monoclonal antibody (mAb) approved by the FDA for use in dogs and works by binding to and inhibiting the biological activity of canine nerve growth factor (NGF), which is involved in the regulation of pain associated with OA. It is administered by subcutaneous injection once a month, making it a convenient and long-term solution for canine OA pain management.

What Are Latest Mergers And Acquisitions In The Canine Arthritis Treatment Market?

In September 2024, Zoetis, a US-based animal health company specializing in veterinary pain management solutions, partnered with the Arthritis Foundation to raise awareness about osteoarthritis (OA) in pets. Through this partnership, Zoetis aims to support educational initiatives that help pet owners recognize OA symptoms in dogs and cats, providing tools to improve early detection and manage OA pain effectively. Arthritis Foundation is a US-based nonprofit organization dedicated to the prevention, control and cure of America's leading cause of disability.

Regional Outlook

North America was the largest region in the canine arthritis treatment market in 2025. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Canine Arthritis Treatment Market?

The canine arthritis treatment market includes revenues earned by entities by providing services such as extracorporeal shockwave therapy (ESWT), acupuncture, and hyaluronic acid supplements. The market value includes the value of related goods sold by the service provider or included within the service offering. The canine arthritis treatment market also includes sales of gabapentin, adequan canine, and metacam. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.